Rationale: Smoking may have multifactorial effects on asthma phenotypes, particularly in severe asthma. Cluster analysis has been applied to explore novel phenotypes, which are not based on any a priori hypotheses.
Smoking may have multifactorial effects on asthma phenotypes, particularly on severe asthma, although it is generally considered to have deleterious effects on asthma (1) . For this clarification, investigators have classified the disease into two or three groups, such as smokers versus nonsmokers, or current smokers versus past smokers versus nonsmokers (2) (3) (4) (5) , and compared the asthma phenotypes between two (or three) groups. However, reports are highly inconsistent, especially regarding the effects of smoking on airway inflammation in asthma; some studies have demonstrated that smoking attenuates eosinophilic inflammation, whereas others describe eosinophilic inflammation induced by smoking (4) (5) (6) (7) (8) (9) (10) .
In contrast, clustering of characteristics using a "data-dependent classification approach" has recently been applied to explore and characterize novel asthma phenotypes, which are not based on any a priori hypotheses (11) (12) (13) (14) (15) (16) (17) . In some studies, variables used for analysis were intentionally selected by researchers (13) (14) (15) , whereas in others they were selected statistically in an attempt to reduce redundancy of variables and to enhance the stability of the analysis (16) (17) (18) . However, either way, the results would be highly affected by the variables selected. Thus, cluster analysis should be considered to generate hypotheses for searching for novel phenotypes of the disease. Given the inconsistent data on the association of smoking with airway inflammation in asthma (4) (5) (6) (7) (8) (9) (10) , it would be intriguing to apply cluster analysis to subjects with severe asthma, focusing particularly on smoking subjects.
In many asthma studies, smokers, particularly heavy smokers, are excluded based on the hypothesis that smoking may affect the characteristics of asthma (11, 12, 16, 17) . In the current study, patients with severe asthma, intentionally including smokers, were recruited. Data were obtained from all subjects during their 2-day stay in Hokkaido University hospital to ensure data quality. The focus was on subjects with severe asthma alone, because it was anticipated that such an approach would more likely elucidate and characterize novel phenotypes, if any, in severe asthma, rather than including a wide variety of patients with mild to moderate asthma, most of whom are well controlled. Specifically, we hypothesized that the effects of smoking on inflammation in asthma would vary and would not affect all subjects in the same way. It was anticipated that cluster analysis would clarify this complexity. Furthermore, one objective was to determine whether severe asthma clusters in Japan would be similar to those identified in previous studies from Western countries. Finally, after classifying severe asthma by clinical clustering analysis, sputum levels of cytokines and/or chemokines were measured in an attempt to characterize the identified phenotypes biologically.
Methods
This study was approved by the ethics committees of all hospitals, and all subjects provided their written, informed consent.
This study was registered in the University hospital Medical Information Network (UMIN) Center Clinical Trials Registry system (https://upload.umin.ac.jp/cgi-openbin/ctr/ctr_view.cgi?recptno=R000003917). Details of the methods are described in our previous reports (19) and the online supplement.
Subject Enrollment
Patients with severe asthma diagnosed by respiratory physicians were enrolled at Hokkaido University Hospital and 29 affiliated hospitals and pulmonary specialist clinics between February 2010 and September 2012. The study inclusion and exclusion criteria are shown in our previous reports (19) . Smokers and subjects with cooccurrence of chronic obstructive pulmonary disease (COPD) and emphysema were not excluded from this study when they were diagnosed as having asthma (19) . Severe asthma was defined based on the American Thoracic Society criteria of refractory asthma in 2000 (20) , with slight modifications (see online supplement and Reference 19) .
Clinical Evaluations at Hokkaido University Hospital
A total of 127 subjects with severe asthma underwent procedural evaluations during their 2-day stay at the Hokkaido University Hospital (19) . Chest and sinus computed tomography scans were performed with patients in the supine position by a multidetector-row spiral computed tomography scanner with a 64-detector array (Aquilion64). The sinus computed 
Results
Detailed characteristics of all subjects are described in Tables 1-3 and the online supplement.
Cluster Analysis Figure 1 shows the dendrogram generated by hierarchical clustering analysis, and Table E2 (in the online supplement) shows the important variables that determine each bifurcation by stepwise discriminant analysis. In the first bifurcation ( Figure 1 ), subjects were classified into two groups on the basis of the %FEV 1 value (preserved %FEV 1 group and low %FEV 1 group). The low %FEV 1 group was further classified into two groups (cluster 3 and cluster 4) (III) according to the FEV 1 /FVC ratio and BMI; The next biclassification of the low FEV 1 /FVC group (IV) was determined by the degree of peripheral eosinophil count and pack-years; cluster 3 was characterized by intense T-helper cell type 2-related indices, whereas cluster 4 was characterized by low T-helper cell type 2-related asthma indices with extremely high pack-years. A schematic diagram of the characteristics of all five clusters is shown in Figure 1 . The detailed characteristics of each cluster are described below. This group had the youngest mean age at onset (22.6 yr), and 83.3% of subjects were atopic. A total of 72.2% of subjects were smokers (11.1% current, 61.1% ex), and the median pack-years was 5.2. The mean peripheral eosinophil count was 307.1 cells/ml, and FE NO was 60.0 ppb. Sputum eosinophils (median, 9.4%) and total serum IgE levels (mean, 448.5 IU/ml) were elevated. The mean %FEV 1 (mean, 104.3%; max value) and FEV 1 /FVC (mean, 75.2%) were normal and higher compared with the four other clusters, respectively. The median sinus score (Lund-Mackay score) was 6. The mean age at onset was 41.6 years. A total of 51.2% of subjects were smokers (4.9% current, 46.3% ex), and the median pack-years was 0.1. Peripheral eosinophil count (mean, 82.3 cells/ml), FE NO (mean, 19.2 ppb), and total serum IgE levels (mean, 42.9 IU/ml) were low. Sputum eosinophil counts were also low (median, 0.8%), whereas the neutrophil count was high (median, 63.8%). The Lund-Mackay score (median, 0) and the prevalence of nasal polyps (9.8%) were low. Cluster 4 (n = 8, 6.3%): low T-helper cell type 2-related indices (low blood/sputum eosinophil, low fractional exhaled nitric oxide, low immunoglobulin E, and low sinus score). The mean age at onset was 44.6 years. All subjects were smokers (50% current, 50% ex), and the median packyears was the highest (72.0). Similar to cluster 3, the mean FEV 1 /FVC was low (mean, 55.8%). The mean low attenuation volume value (mean, 3.89%) was the highest, and percentage transfer coefficient of the lung for carbon monoxide (mean, 84.8%) was the lowest, although within normal limits, among the five clusters. In contrast with cluster 3, peripheral and sputum eosinophils (mean, 69.0 cells/ml; median, 0.8%, respectively), FE NO (mean, 21.5 ppb), and total serum IgE (mean, 51.0 IU/ml) levels were low. Lund-Mackay score (median, 1) and the prevalence of nasal polyps (0%) were very low. Thus, these subjects appeared to have mild to moderate COPD together with the clinical phenotype of severe asthma. The mean age at onset was 46.4 years. This cluster was female dominant (85%), with a high mean BMI (31.0 kg/m 2 ); 80.0% of subjects were never smokers (5.0% current smokers, 15.0% ex-smokers). The mean blood and sputum eosinophils (mean, 526.4 cells/ml; median, 24.8%, respectively) and FE NO (mean, 62.7 ppb) were high. The mean percentage of functional residual capacity (mean, 83.0%), and percentage of vital capacity (mean, 89.9%), were the lowest among the five clusters. The sinus score (Lund-Mackay score: median, 11) was also high. To address biological differences among the five clinically defined clusters, biomarkers in sputum were compared among the five clusters (Table 4 and Figure 2 ). Interleukin-5, interleukin-6, epidermal growth factor, monocyte chemoattractant protein-1, and osteopontin showed significant differences (P , 0.05) among the five groups (Table  E6) . interleukin-5 levels were high in clusters 3 and 5, whereas osteopontin and interleukin-6 levels were high in cluster 4. In addition, radar charts provided the distinct pattern of biomarkers in the sputum visually for each cluster (Figure 2 ).
Stability of Clinical Variables after 3-Year Follow-Up
Of the 127 subjects, 101 subjects were successfully reevaluated using several clinical parameters, including peripheral eosinophil count, FE NO , total serum IgE level, and pulmonary function tests. Tables E7 and E8 show the clinical characteristics for five clusters using the data obtained at 3-year follow-up. When parameters obtained at 3-year follow-up were applied and plotted to each cluster, similar results were confirmed, as shown in Figure E2 .
Discussion
In this study, we applied a clinical clustering approach to 127 adult patients with severe asthma, a large percent of whom had a current or past smoking history. We identified five distinct phenotypes, two of which clearly showed low forced expiratory volume in 1 second/forced vital capacity (clusters 3 and 4). A total of 72.5% of subjects (29 of 40) in cluster 3 and all of 8 subjects in cluster 4 were smokers. When two smoking groups with low forced In the first bifurcation (I), subjects were classified into two groups on the basis of the predicted forced expiratory volume in 1 second (%FEV 1 ) value (preserved %FEV 1 group and low %FEV 1 group). The low %FEV 1 group was further classified into two groups (cluster 3 and cluster 4) (III) according to the FEV 1 /forced vital capacity (FVC) ratio and body mass index (BMI); the next biclassification of the low FEV 1 /FVC group (IV) was determined by the degree of peripheral eosinophil count and pack-years; cluster 3 was characterized by intense T-helper cell type 2 (Th2)-related indices, whereas cluster 4 was characterized by low Th2-related asthma indices with extremely high pack-years. Table E2 in the online supplement shows the important variables that determine each bifurcation by stepwise discriminant analysis. IgE = immunoglobulin E; LMS = Lund-Mackay score.
ORIGINAL RESEARCH expiratory volume in 1 second/forced vital capacity were compared, they appeared to differ by type of peripheral and airway inflammation. The amount and pattern of cytokines and/or chemokines in sputum in the five clusters suggested distinct airway inflammation patterns behind the five clusters. Considering the high smoking rate in Japan and worldwide (26) , inclusion of smokers in the severe asthma study more precisely reflects the "real world" of severe asthma, where smoking rates are reported to reflect those in the general population. Asthma was defined on the basis of the patients' episodic respiratory symptoms, together with demonstrable reversible airflow obstruction at some time during their history. Low mean bronchodilator response values of patients (Table 3) at entry were likely attributable to the response measured while they were on full medication. Airway remodeling may also explain the low mean bronchodilator response values (27) . Importantly, subjects with characteristics of coexisting chronic obstructive pulmonary disease were not excluded in this study if they also had features of asthma.
In many previous studies, smoking was associated with a less eosinophilic inflammatory pattern (3) (4) (5) . Such a conclusion was largely drawn based on the comparison between smokers and nonsmokers. In this study, the subjects classified into cluster 4 were all smokers, and their median pack-years were the highest among the five clusters. Subjects in this cluster were characterized by a fixed low forced expiratory volume in 1 second/ forced vital capacity ratio (average, 55.8%) and low levels of eosinophils, immunoglobulin E, fractional exhaled nitric oxide, and sinus score, results that differ markedly from typical eosinophilic asthma. In addition, relatively low percentage transfer coefficient of the lung for carbon monoxide and high low attenuation volume in cluster 4 subjects evidently support a coexistence of emphysema. On the other hand, some previous studies describe smoking patients with asthma characterized by eosinophilic inflammation (6) (7) (8) , and these observations are consistent with the characteristics of the smoking subjects classified into cluster 3 (n = 29) in the present study. Similar to cluster 4, there was a fixed airflow limitation; the mean forced expiratory volume in 1 second/forced vital capacity was as low as 55.6%. However, this group differed markedly from cluster 4 on the basis of the presence of blood and sputum eosinophils. High levels of fractional exhaled nitric oxide and serum immunoglobulin E were another feature, and are likely linked to a T-helper cell type 2-high inflammatory response. Like typical eosinophilic asthma, the sinus score was high, and the prevalence of nasal polyps was also high in the subjects of this cluster. In short, although this group seems to be heavily affected by smoking, like cluster 4, these two groups differ in the nature of airway inflammation. Meanwhile, nonsmoking subjects in cluster 3 (n = 11) represent typical characteristics of severe ORIGINAL RESEARCH asthma with fixed airflow limitation associated with eosinophilic inflammation. Moreover, comprehensive measurements of cytokine and/or chemokine levels in sputum also showed differing profiles between the two clusters (Table E6, Figure 2 ): cluster 3 subjects had high C-C motif chemokine ligand 11 and interleukin-5 levels, whereas cluster 4 subjects had high interleukin-6 and osteopontin levels. Indeed, recent studies have also shown increased levels of interleukin-6 and osteopontin in sputum from subjects with asthma who smoke (24, 28, 29) , and this was correlated with the number of neutrophils. These results are consistent with those for cluster 4 from the current study but not necessarily so for all of the smoking subjects. These results may explain the aforementioned inconsistent results of the previous reports on the effect of smoking on asthma phenotypes and suggest that two distinct biological pathways exist for development of fixed airflow limitation in severe asthma.
Besides the two groups that were characterized by smoking and low forced expiratory volume in 1 second/forced vital capacity, we recognize that among the other three clusters, two are similar to those identified in several studies conducted in Western countries. Cluster 1 alone was characterized by predominantly atopic and younger onset age than that of the four other clusters. Cluster 5, which is characterized by a high body mass index and female predominance, is similar to that identified in Western people (11, 12) . A high body mass index-associated increase in abdominal fat may decrease lung volumes, such as percentage of functional residual capacity, in these patients. Thus, obesity directly affects respiratory mechanics, and this may partly explain the severity of asthma in patients in this cluster. Interestingly and unexpectedly, the subjects in cluster 5 showed mainly eosinophilic inflammation, which is in contrast to some previous studies that reported predominantly noneosinophilic inflammation in the cluster with high body mass index and female predominance (11, 12, 30, 31) . The reason for this discrepancy is unclear, but differences in genetic background, the inclusion of smokers, and the relatively lower mean body mass index in the present population may have influenced these results. Considering other reports, which demonstrated a significant association of obesity with eosinophilic airway inflammation and high interleukin-5 levels in sputum (32, 33) , the results in the present study seem to support such an association. Cluster 2 is characterized by less eosinophilic inflammation (predominantly neutrophilic), despite fewer pack-years. The inflammatory nature of this cluster is similar to that of cluster 4, but the cytokine/chemokine profiles in sputum ORIGINAL RESEARCH appear to differ on the radar charts (Figure 2 ), suggesting biological differences in the pathogeneses of these two clusters. Although the efficacy of several biologics targeted against T-helper cell type 2-highrelated molecules, such as immunoglobulin E, interleukin-5, or interleukin-4/13, has been recently demonstrated (34) , the subjects in these two clusters may be relatively resistant to these therapies. Future studies should also be focused on these lesseosinophilic phenotypes, and the cytokine/ chemokine profiles shown by radar charts in this study may help identify the candidate targets for subjects in these two clusters. This study has several significant limitations. First, the sample size is small, despite recruitment of subjects from 29 affiliated hospitals/pulmonary clinics. However, a unified protocol in the 2-day stay at Hokkaido University hospital ensured a high quality of data acquisition. Second, we used the old definition of severe asthma that was developed by the American Thoracic Society workshop in 2000 (20) , because the new definition by European Respiratory Society/American Thoracic Society guidelines (35) had not been officially announced when this study was designed. However, we confirmed that subjects experienced episodic deterioration of symptoms or an increase in urgent care visits or in rescue use of short-acting bronchodilators when their current medication was reduced within 1 year (see MATERIAL AND METHODS in the online supplement). Thus, all subjects were certainly in conditions where high doses of inhaled corticosteroids or oral corticosteroids were required for asthma control. Third, even if we intentionally attempted to recruit smoking subjects with asthma regardless of coexisting chronic obstructive pulmonary disease, it is likely that physicians did not include heavy smokers who had predominantly chronic obstructive pulmonary disease characteristics such as emphysema, leading to omission of heavy smokers in this study. It should be noted that percentage transfer coefficient of the lung for carbon monoxide values are reported to be normal to high in asthma (36) . Last, because of the crosssectional nature of this study, we were unable to discuss the trajectory of change in pulmonary functions, particularly for subjects in clusters 3 and 4-how these patients developed fixed airflow limitation.
To prospectively evaluate the declines in the forced expiratory volume in 1 second, our study is ongoing to reach up to 6 years of follow-up. Although we completed a 3-year follow-up for all subjects, we believe that 3 years is insufficient to determine individual changes in forced expiratory volume in 1 second because of the variable nature of pulmonary function in patients with severe asthma. Accordingly, longitudinal changes in forced expiratory volume in 1 second for subjects in each cluster can be clarified in future analyses.
The cluster analysis used here may have some inherent limitations, including the somewhat intentional variable selection, with potential biases for smoking-related and pulmonary function parameters. The final selection of five clusters was meaningful and attractive, but not appropriately confirmed as to stability. We only confirmed the reproducibility of some key parameters over 3 years in this study. However, it is well known that any cluster analyses most often contain some clinical or scientific biases. Rather, these studies are best used for hypothesis generation.
In conclusion, the cluster analysis in this study, which focused only on patients with severe asthma, provided two distinct phenotypes with potentially different biological pathways contributing to fixed airflow limitation in cigarette smokers with severe asthma. These results represent the first cluster analysis of smoking in relation to severe asthma, and this should facilitate further studies. n
